Mod­er­na’s ‘year of tran­si­tion’: Chang­ing gears from Covid-19 to RSV as vac­cine ap­proval date looms

Wrap­ping what it calls a “year of tran­si­tion,” Mod­er­na is fur­ther ex­pand­ing its com­mer­cial op­er­a­tions to­ward the po­ten­tial launch of its RSV vac­cine while down­siz­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER